US Patent 10786561 Immunogenic compositions for use in pneumococcal vaccines
Patent 10786561 was granted and assigned to Pfizer Limited on September, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 19 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
107865610
Date of Patent
September 29, 2020
0Patent Application Number
157754850
Date Filed
November 7, 2016
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 23 Mar, 2023
Golden AI
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
107865610
Date of Patent
September 29, 2020
0Patent Application Number
157754850
Date Filed
November 7, 2016
0Official Website
Patent Citations
Patent Citations Received
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Edits on 6 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 10786561 Immunogenic compositions for use in pneumococcal vaccines
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10786561
Date of patent
September 29, 2020
Patent application number
15775485
Date Filed
November 7, 2016
Patent citations
Patent primary examiner
Find more entities like US Patent 10786561 Immunogenic compositions for use in pneumococcal vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
